ArticleBMJ open respiratory research2021

Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population.

Hironori Sagara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.